Shengping D. Li
State Key Laboratory Of Oncology In South China, PR
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications
Efficacy of immune checkpoint inhibitors combined with different chemotherapy in recurrent pancreatic cancer: a retrospective study.
Journal: Frontiers in immunology
Published: March 30, 2026
Anti-PD-1 blockade reverses low-intensity electric stimulation-driven pancreatic cancer progression.
Anti-PD-1 blockade reverses low-intensity electric stimulation-driven pancreatic cancer progression.
Journal: Frontiers in immunology
Published: January 21, 2026
Development of a nomogram integrating immune checkpoints, fibrosis indicators, and clinicopathological characteristics to predict overall survival in pancreatic cancer: a retrospective analysis.
Journal: Frontiers in immunology
Published: August 19, 2025
Efficacy of irreversible electroporation combined with immunotherapy versus irreversible electroporation alone in locally advanced pancreatic cancer: a propensity score-matched retrospective study.
Journal: Frontiers in immunology
Published: April 30, 2025
Development of a Nomogram Integrating Modified Inflammation-Based Indexes for Predicting Overall Survival in Pancreatic Cancer: A Retrospective Study.
Journal: Journal of inflammation research
Published: January 27, 2025
Genome-wide association study of HBV-related hepatocellular carcinoma identifies a functional variant at the FAM114A1 locus.
Journal: Journal of genetics and genomics = Yi chuan xue bao
Published: December 22, 2024
Treatment of locally advanced pancreatic cancer with irreversible electroporation and intraoperative radiotherapy.
Journal: Hepatobiliary surgery and nutrition
Published: September 19, 2024
Nomogram for predicting post-progression-free survival in patients with recurrent pancreatic ductal adenocarcinoma after radical surgery: a retrospective analysis.
Journal: Frontiers in medicine
Published: August 26, 2024
Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration.
Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration.
Journal: Cancer immunology, immunotherapy : CII
Published: April 07, 2024
Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer [Cancer Lett. 502 (2021) 9-24].
Journal: Cancer letters
Published: February 13, 2024
Multimodal single cell-resolved spatial proteomics reveal pancreatic tumor heterogeneity.
Journal: Nature communications
Published: October 20, 2023
Position Tracking of Multiple Robotic Manipulator Systems Associated with Communication Strength Dynamics.
Journal: Sensors (Basel, Switzerland)
Published: September 15, 2023
Last Updated: 09/26/2026